Psychedelic-Assisted Therapy No More Effective Than Antidepressants

THURSDAY, March 19, 2026 (HealthDay News) -- Psychedelic-assisted therapy (PAT) is no more effective than traditional antidepressants (TADs) for treatment of major depression, according to a review published online March 19 in JAMA Psychiatry. Zachary J. Williams, M.D., Ph.D., from the University of California in Los Angeles, and colleagues conducted a systematic literature review to examine the comparative effectiveness of PAT versus open-label TADs for the treatment of major depression. The mean within-arm effect from baseline to primary end point (patient improvement between PAT and open-label TAD trials on the 17-item Hamilton Depression Rating Scale) was compared following predefined hypotheses. The potential role of blinding was assessed by comparing the within-arm effect of blinded versus open-label trials in both PAT and TADs. Twenty-four studies met the inclusion criteria.The researchers found that PAT (eight trials; 249 patients) was no more effective than open-label TAD treatment (16 trials; 7,921 patients), contrary to the first of three hypotheses. Compared with blinded treatment, open-label TADs were associated with better outcomes, with an estimated difference of 1.3; the same difference was not seen for PAT."Unblinding is the defining methodological problem of psychedelic trials. What I wanted to show is that even if you compare psychedelics to open-label antidepressants, psychedelics are still much better," lead author Balázs Szigeti, Ph.D., from the University of California in San Francisco, said in a statement. "Unfortunately, what we got is the opposite result -- that they are the same, which is very surprising given the enthusiasm around psychedelics and mental health."One author disclosed ties to Roche.Abstract/Full Text (subscription or payment may be required).Sign up for our weekly HealthDay newsletter

Psychedelic-Assisted Therapy No More Effective Than Antidepressants

Related Stories

Review Links ADHD With Increased Mortality Across Various Causes

Ultraprocessed Food Intake Linked to Adiposity, Vascular Brain Injury

High Viral Suppression Found for Patients With HIV Receiving Long-Acting LEN/CAB

Undeclared Pharmacologically Active Ingredients ID'd in OTC Skin Products